Delivery Order SPE2DB24D3015-SPE2DB24FFWYM
Award Date
7/17/24
Potential Completion Date
8/7/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award worth $6,461.32 to AmerisourceBergen Drug Corporation's Corporate Office Division by the Defense Logistics Agency (DLA). The order is for the pharmaceutical product Envarsus XR 4 mg tablet, which is a critical medical supply. The contract has a completion date of September 27, 2024 and is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, particularly the Department of Defense and...
This federal contract award, valued at $5,135.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Envarsus XR 4 mg tablets, a pharmaceutical product, with a performance period through May 27, 2025. This contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Envarsus XR 1 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order has a potential value of $1,216.11 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this contract, which is not designated as a set-aside. The company holds an indefinite delivery contract...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,007.34, is for the delivery of Envarsus XR 1 mg tablets in quantities of 100. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. Amerisourcebergen Drug Corp is the prime contractor, and the contract will be performed in Conshohocken,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Envarsus XR 4 mg tablets. The contract is a Delivery Order with a Firm Fixed Price type, valued at $1,981.75, and has an ultimate completion date of September 30, 2024. The contract was awarded on September 9, 2024 and is not set-aside. Amerisourcebergen, through its Corporate Office division, has been awarded various federal...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Envarsus XR 1 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price and a ceiling value of $1,621.48. It has an ultimate completion date of July 31, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,026.85, is for the supply of Envarsus XR 1 mg tablets. The award has an ultimate completion date of November 13, 2024 and uses a firm fixed-price pricing type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Envarsus XR 1 mg tablets over a period ending June 7, 2024. The contract, valued at $1,465.68, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on May 16, 2024. This is a delivery order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. The...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is a delivery order (SPE2DB24D2205|SPE2DB25FECDF) with a ceiling value of $3,423.90. The contract is for the supply of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract is not set-aside and has an ultimate completion date of June 2, 2025. Amerisourcebergen Drug Corp. is the prime contractor for this award, which is part of a larger Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Envarsus XR 1 mg tablet in quantities of 30. The $1,465.68 ceiling value Firm Fixed Price contract was awarded on June 11, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of July 3, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a...